INGNInogen Inc

Nasdaq inogen.com


$ 8.46 $ -0.23 (-2.65 %)    

Friday, 10-May-2024 15:59:50 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 8.46
$ 8.80
$ 0.00 x 0
$ 0.00 x 0
$ 8.42 - $ 8.88
$ 4.13 - $ 11.98
494,813
na
197.98M
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-01-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 04-30-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-14-2016 12-31-2015 10-K
35 11-10-2015 09-30-2015 10-Q
36 08-11-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 04-27-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-maintains-hold-on-inogen-raises-price-target-to-7

Stifel analyst Mathew Blackman maintains Inogen (NASDAQ:INGN) with a Hold and raises the price target from $6 to $7.

 needham-reiterates-hold-on-inogen
Needham Reiterates Hold on Inogen
05/08/2024 09:48:32

Needham analyst Mike Matson reiterates Inogen (NASDAQ:INGN) with a Hold.

 inogen-q1-2024-adj-eps-045-beats-076-estimate-sales-78025m-beat-73663m-estimate

Inogen (NASDAQ:INGN) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.76) by 40....

 needham-reiterates-hold-on-inogen
Needham Reiterates Hold on Inogen
04/09/2024 15:55:31

Needham analyst Mike Matson reiterates Inogen (NASDAQ:INGN) with a Hold.

 sp-500-edges-lower-adt-posts-upbeat-earnings

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow t...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 why-is-inogen-stock-plummeting-today

Inogen reported Q4 2023 revenues of $75.9 million, missing consensus. Despite challenges, the company's improvements positi...

 nasdaq-down-50-points-us-crude-stocks-rise-by-42m-barrels

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow trad...

 inogen-shares-resume-trade
Inogen Shares Resume Trade
02/28/2024 14:37:34

 inogen-q4-2023-adj-eps-083-misses-062-estimate-sales-7590m-miss-7699m-estimate

Inogen (NASDAQ:INGN) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.62) by 3...

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 inogen-earnings-preview
Inogen Earnings Preview
02/26/2024 20:01:43

 competitor-exit-a-boom-for-respiratory-device-focused-inogen-earns-analyst-upgrade

Impact of Philips' decision to halt CPAP device sales in the U.S. and its potential market implications. William Blair sees...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION